Viridian Therapeutics, Inc. (VRDN)
17.06
-0.47
(-2.68%)
USD |
NASDAQ |
May 07, 14:10
Viridian Therapeutics SG&A Expense (TTM) : 78.21M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.965B |
| Boston Scientific Corp. | 7.072B |
| Marker Therapeutics, Inc. | 4.185M |
| Plus Therapeutics, Inc. | 12.13M |
| Nutriband, Inc. | 6.993M |